GlassScriptPhysician profile
Tiffany Pike-Lee
NPI 1043604127
$288.30
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Neuromuscular Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $79.18 · 2021: $193 · 2022: $16.42.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $65.96 | 2021 | |
| Abbvie INC. | $40.61 | 2021-2022 | |
| Biogen, INC. | $36.01 | 2020-2021 | |
| Lilly USA, LLC | $24.38 | 2021 | |
| Genentech USA, INC. | $23.68 | 2020 | |
| Csl Behring | $22.67 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $18.17 | 2021 | |
| Xeris Pharmaceuticals, INC. | $16.21 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.69 | 2021 | |
| Ucb, INC. | $14.02 | 2021 | |
| Avanir Pharmaceuticals, INC. | $11.90 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Pike-Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.